Combined bone marrow and solid organ transplantation with alemtuzumab induction

  • Ron Shapiro
  • , Velma P. Scantlebury
  • , Mark L. Jordan
  • , Robert J. Corry
  • , Santosh Potdar
  • , Ashokkumar Jain
  • , Carlos A. Vivas
  • , Parmjeet Randhawa
  • , Amit Basu
  • , Cynthia Smetanka
  • , Edward A. Gray
  • , Noriko Murase
  • , Jennifer Woodward
  • , Adriana Zeevi
  • , Anthony J. Demetris
  • , John J. Fung
  • , Amadeo Marcos
  • , Thomas E. Starzl

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

In summary, a combination of high-dose antibody therapy as a preconditioning agent and low-dose tacrolimus as a maintenance therapy appears to allow slow tapering of immunosuppression to remarkably low levels.

Original languageEnglish (US)
Pages (from-to)S18-S19
JournalTransplantation Reviews
Volume17
Issue number4 SUPPL.
DOIs
StatePublished - Oct 2003

All Science Journal Classification (ASJC) codes

  • Transplantation

Fingerprint

Dive into the research topics of 'Combined bone marrow and solid organ transplantation with alemtuzumab induction'. Together they form a unique fingerprint.

Cite this